151 related articles for article (PubMed ID: 36633687)
1. Assessment of the potency and effectiveness of a heptavalent oil-adjuvanted (ISA 206) foot-and-mouth disease vaccine in Egypt.
Bazid AH; Amer HM; Nayel M; Attia M; Maklad N; Wasfy M; Abdelmegeid M; El-Sayed MM; Magouz A; Badr Y
Arch Virol; 2023 Jan; 168(2):62. PubMed ID: 36633687
[TBL] [Abstract][Full Text] [Related]
2. Montanide ISA™ 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle.
Dar P; Kalaivanan R; Sied N; Mamo B; Kishore S; Suryanarayana VV; Kondabattula G
Vaccine; 2013 Jul; 31(33):3327-32. PubMed ID: 23735678
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep.
Singanallur NB; Pacheco JM; Arzt J; Stenfeldt C; Fosgate GT; Rodriguez L; Vosloo W
Antiviral Res; 2017 Sep; 145():114-122. PubMed ID: 28780422
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of different adjuvants for foot-and-mouth disease vaccine containing all the SAT serotypes.
Cloete M; Dungu B; Van Staden LI; Ismail-Cassim N; Vosloo W
Onderstepoort J Vet Res; 2008 Mar; 75(1):17-31. PubMed ID: 18575060
[TBL] [Abstract][Full Text] [Related]
5. Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers.
Sitt T; Kenney M; Barrera J; Pandya M; Eckstrom K; Warner M; Pacheco JM; LaRocco M; Palarea-Albaladejo J; Brake D; Rieder E; Arzt J; Barlow JW; Golde WT
Vaccine; 2019 Sep; 37(42):6221-6231. PubMed ID: 31493951
[TBL] [Abstract][Full Text] [Related]
6. DNA vaccine (P1-2A-3C-pCDNA) co-administered with Bovine IL-18 gives protective immune response against Foot and Mouth Disease in cattle.
Kotla S; Sanghratna Vishanath B; H J D; K G; V V S S; Reddy GR
Vet Microbiol; 2016 Sep; 193():106-15. PubMed ID: 27599937
[TBL] [Abstract][Full Text] [Related]
7. The effects of simultaneous foot-and-mouth disease and Escherichia coli vaccination on the immunity of pregnant cows and their calves.
Tuncer-Göktuna P; Malal ME; Sareyyüpoğlu B; Çokçalişkan C; Taşçene N; Uzun EA; Arslan A; Gündüzalp C; Balci GN; Çökülgen T; Asar E; Ateşoğlu A; Gülyaz V
Prev Vet Med; 2022 Jul; 204():105645. PubMed ID: 35453090
[TBL] [Abstract][Full Text] [Related]
8. Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine.
Barrera J; Brake DA; Schutta C; Ettyreddy D; Kamicker BJ; Rasmussen MV; Bravo de Rueda C; Zurita M; Pisano M; Hurtle W; Brough DE; Butman BT; Harper BG; Neilan JG
Vaccine; 2018 Nov; 36(48):7345-7352. PubMed ID: 30327212
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled field trial assessing foot and mouth disease vaccine effectiveness in Gondar Zuria district, Northwest Ethiopia.
Jemberu WT; Molla W; Fentie T
Prev Vet Med; 2020 Oct; 183():105136. PubMed ID: 32977170
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of cross-protection between O1 Manisa and O1 Campos in cattle vaccinated with foot-and-mouth disease virus vaccine incorporating different payloads of inactivated O1 Manisa antigen.
Nagendrakumar SB; Srinivasan VA; Madhanmohan M; Yuvaraj S; Parida S; Di Nardo A; Horsington J; Paton DJ
Vaccine; 2011 Feb; 29(10):1906-12. PubMed ID: 21236232
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of high-potency FMDV O
Horsington J; Perez CB; Maradei E; Novo SG; Gonzales JL; Singanallur NB; Bonastre P; Vosloo W
Vaccine; 2017 Sep; 35(38):5179-5185. PubMed ID: 28789849
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a high potency O
Fishbourne E; Ludi AB; Wilsden G; Hamblin P; Statham B; Bin-Tarif A; Brocchi E; Grazioli S; Dekker A; Eblé P; King DP
Vaccine; 2017 May; 35(20):2761-2765. PubMed ID: 28396208
[TBL] [Abstract][Full Text] [Related]
13. Compared to Aluminum Hydroxide Adjuvant, Montanide ISA 206 VG Induces a Higher and More Durable Neutralizing Antibody Response against FMDV in Goats.
Taghizadeh M; Azimi SM; Dabaghian M
Arch Razi Inst; 2023 Dec; 78(6):1843-1851. PubMed ID: 38828163
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the effectiveness of foot-and-mouth disease vaccination of animals in the buffer zone of the Republic of Armenia in 2016-2020.
Kharatyan S; Sargsyan K; Elbakyan H; Markosyan T; Tumanyan P; Hakobyan V; Sargsyan V; Badalyan M; Chobanyan G; Achenbach JE
BMC Vet Res; 2023 Sep; 19(1):176. PubMed ID: 37773157
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a foot-and-mouth disease vaccine against a heterologous SAT1 virus challenge in goats.
Lazarus DD; Peta F; Blight D; Van Heerden J; Mutowembwa PB; Heath L; Blignaut B; Opperman PA; Fosgate GT
Vaccine; 2020 May; 38(24):4006-4015. PubMed ID: 32312581
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle.
Sreenivasa BP; Mohapatra JK; Pauszek SJ; Koster M; Dhanya VC; Tamil Selvan RP; Hosamani M; Saravanan P; Basagoudanavar SH; de Los Santos T; Venkataramanan R; Rodriguez LL; Grubman MJ
Vet Microbiol; 2017 May; 203():196-201. PubMed ID: 28619144
[TBL] [Abstract][Full Text] [Related]
17. Humoral Immune Response in Calves Vaccinated with Monovalent Vaccines or a Trivalent Combination Thereof and Matching of These Vaccines to the Selected Circulating Foot-and-Mouth Disease Viruses in Ethiopia.
Woldemariyam FT; Negessu D; Bilata T; Muluneh A; Gebreweld DS; Ebisa IT; Paeshuyse J
Vaccines (Basel); 2023 Aug; 11(8):. PubMed ID: 37631920
[TBL] [Abstract][Full Text] [Related]
18. Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine.
Barrera J; Schutta C; Pisano M; Grubman MJ; Brake DA; Miller T; Kamicker BJ; Olutunmbi F; Ettyreddy D; Brough DE; Butman BT; Neilan JG
Vaccine; 2018 Feb; 36(8):1078-1084. PubMed ID: 29358056
[TBL] [Abstract][Full Text] [Related]
19. Co-infection with different serotypes of FMDV in vaccinated cattle in Southern Egypt.
Al-Hosary AA; Kandeil A; El-Taweel AN; Nordengrahn A; Merza M; Badra R; Kayali G; Ali MA
Virus Genes; 2019 Jun; 55(3):304-313. PubMed ID: 30771081
[TBL] [Abstract][Full Text] [Related]
20. Development and serology based efficacy assessment of a trivalent foot-and-mouth disease vaccine.
Al Amin M; Ali MR; Islam MR; Alam ASMRU; Shill DK; Rahman MS; Siddique MA; Sultana M; Hossain MA
Vaccine; 2020 Jul; 38(32):4970-4978. PubMed ID: 32535015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
